Skip to main content
Journal ArticleOPEN ACCESS

Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability

  • Strickler J
  • Hurwitz H
The Oncologist (2012) 17(1) 9-10
DOI: 10.1634/theoncologist.2011-0358
6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.

Cite

CITATION STYLE

APA

Strickler, J. H., & Hurwitz, H. I. (2012). Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability. The Oncologist, 17(1), 9–10. https://doi.org/10.1634/theoncologist.2011-0358

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free